We reply within one business dayGet my quote
Type 2 diabetes: US-approved treatments and how Gulf families can access them
A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.
Reviewed by the Reserve Meds clinical operations team on 17 October 2026.
Type 2 diabetes: the short answer
The US FDA has approved four medicines on this page for type 2 diabetes, each for specific patients. Four of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.
- US FDA-approved medicines on this page: Mounjaro, Ozempic, Jardiance and Farxiga.
- Gulf registration (checked 17 October 2026): see each medicine below.
- Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital.
- Price: Quote on request.
What is type 2 diabetes?
Type 2 diabetes is a disease in which blood glucose is too high because the body does not make enough insulin or does not use it well. It usually starts with insulin resistance, when cells do not respond normally to insulin.[1]
Risk factors include overweight or obesity, physical inactivity, family history and age over 45, although younger people can also get it. Symptoms develop slowly and include frequent urination, thirst, tiredness, blurred vision, tingling in the hands and feet and sores that heal poorly.[1, 2]
Treatment combines healthy eating, activity and medicines. In the US, several newer medicines improve blood glucose and some also reduce the risk of heart or kidney problems in people with type 2 diabetes, including weekly injections and daily tablets.[3, 4, 5, 6]
Type 2 diabetes in the Gulf
A review of type 2 diabetes in the GCC countries reported prevalence between 8% and 22% according to the International Diabetes Federation, linked to obesity, unhealthy lifestyle, longer life expectancy, rising diabetes in young people and genetic susceptibility.[7]
US FDA-approved medicines for type 2 diabetes
Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.
- Mounjaro (tirzepatide)
FDA-approved for improving blood glucose, together with diet and exercise, in adults and children 10 years and older with type 2 diabetes, and reducing major cardiovascular events in some adults, as listed in the label. It is a weekly injection.[3]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[8, 9]
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, India, Pakistan - Ozempic (semaglutide)
FDA-approved for improving blood glucose, together with diet and exercise, in adults with type 2 diabetes, and reducing the risk of major cardiovascular events and kidney decline in some adults, as listed in the label. It is a weekly injection.[4]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[8, 9]
Country guides: Saudi Arabia, UAE, Egypt, India, Pakistan - Jardiance (empagliflozin)
FDA-approved for improving blood glucose in adults and children 10 years and older with type 2 diabetes, and reducing cardiovascular death in adults with type 2 diabetes and heart disease, plus heart failure and kidney uses listed in the label. It is a daily tablet.[5]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[8, 9]
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, India - Farxiga (dapagliflozin)
FDA-approved for improving blood glucose in adults and children 10 years and older with type 2 diabetes, and reducing hospitalization for heart failure in some adults with type 2 diabetes, plus heart failure and kidney uses listed in the label. It is a daily tablet.[6]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list (as Forxiga). Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list (as Forxiga). Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[8, 9]
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, India
How families in the Gulf can access these medicines
If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.
If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.[10, 11] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.
Who does what
- Your treating specialist decides whether a medicine is right for the patient and writes the letter.
- The hospital checks local supply, files any import request, and gives the treatment safely.
- The national regulator decides whether to approve the import of a medicine that is not registered.
- The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
- Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.
Documents you will usually need
- A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
- Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
- Recent clinic notes and a list of current medicines
- For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
- Proof of the US FDA approval and the US prescribing information (we can supply these)
We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.
What treatment costs
Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.
Ask us about treatment for type 2 diabetes
Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is there an FDA-approved treatment for type 2 diabetes?
Yes. The medicines on this page have US FDA approval for specific groups of patients: Mounjaro, Ozempic, Jardiance and Farxiga. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.
Is Mounjaro available in Saudi Arabia or the UAE?
Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.
How can a family in the Gulf get Mounjaro?
Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.
How much does treatment cost?
Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.
Are these medicines widely available in the Gulf?
Several are listed in Gulf registers, sometimes under a different brand name such as Forxiga. Check the register line under each medicine. If it is available locally, you may not need an import.
Can type 2 diabetes be managed without medicine?
Healthy eating, physical activity and weight management are the base of treatment, as MedlinePlus explains. Many people also need medicine. Your doctor decides.
Sources for the last two answers: [8, 9] [1]
Sources
Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.
- MedlinePlus (US National Library of Medicine): Diabetes Type 2
- MedlinePlus Genetics (US National Library of Medicine): Type 2 diabetes
- DailyMed (US National Library of Medicine): Mounjaro (tirzepatide) US prescribing information, version published 2 September 2026
- DailyMed (US National Library of Medicine): Ozempic (semaglutide) US prescribing information, version published 10 June 2026
- DailyMed (US National Library of Medicine): Jardiance (empagliflozin) US prescribing information, version published 2 February 2026
- DailyMed (US National Library of Medicine): Farxiga (dapagliflozin) US prescribing information, version published 11 September 2026
- Aljulifi et al. Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries. Saudi Med J 2021 (PubMed 33896777)
- SFDA: Drugs List, public register (all 9,173 entries checked by brand name on 17 October 2026)
- Department of Health Abu Dhabi: drug code list Drugs.xlsx (release 26 September 2026, effective 2 October 2026)
- SFDA: Special Access Program (SAP) guidance, version 1.0
- NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products
Related
- Obesity
- MASH (formerly NASH)
- Type 1 diabetes
- Named-patient access in the Gulf, explained
- Answers to common access questions
- Cross-border disclosures
- اقرأ هذه الصفحة بالعربية
- यह पृष्ठ हिंदी में पढ़ें
- یہ صفحہ اردو میں پڑھیں
This page is general health information, not medical advice. It does not replace a consultation with your doctor.